Hirva Mamdani - Concepedia

Author

Hirva Mamdani

The Barbara Ann Karmanos Cancer Institute ORCID

Also Known As

H. Mamdani, Hirva Mamdani, Hirva Mansurali Mamdani

251

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

The Barbara Ann Karmanos Cancer Institute Wayne State University Indiana University – Purdue University Indianapolis Sarah Cannon City of Hope

About

Hirva Mamdani is an author at The Barbara Ann Karmanos Cancer Institute specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	16	345
2	Cell Biology	6	6	143
3	Health Sciences	4	4	74
4	Engineering	1	1	11
5	Genetic Medicine	1	1	45

Hirva Mamdani

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline Navneet Singh, Sarah Temin, Sherman Baker, Journal of Clinical Oncology	2022	118
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline Navneet Singh, Sarah Temin, Sherman Baker, Journal of Clinical Oncology	2022	109
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies Melissa L. Johnson, Anthony B. El-Khoueiry, Navid Hafez, Clinical Cancer Research	2021	56
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1 Navneet Singh, Ishmael Jaiyesimi, Nofisat Ismaila, Journal of Clinical Oncology	2023	49
Interim results of an ongoing phase 1/2a study of HPN328, a tri-specific, half-life extended, DLL3-targeting, T-cell engager, in patients with small cell lung cancer and other neuroendocrine cancers. Melissa L. Johnson, Grace K. Dy, Hirva Mamdani, Journal of Clinical Oncology Sclc PtsImmunologyImmunoeditingOngoing Phase 1/2AOncology	2022	45
Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4) Robin Cornelissen, Arsela Prelaj, Sophie Sun, Journal of Thoracic Oncology Cohort 4Mendelian DisorderPathologyA MulticenterPharmacotherapy	2023	45
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer Nobuyuki Takahashi, Zhonglin Hao, Liza C. Villaruz, JAMA Oncology	2023	41
A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study Hirva Mamdani, Bryan J. Schneider, Susan M. Perkins, Frontiers in Oncology	2021	39
Novel therapies in small cell lung cancer. Hirva Mamdani, Raghava R. Induru, Shadia I. Jalal PubMed	2015	33
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2 Dwight H. Owen, Navneet Singh, Nofisat Ismaila, Journal of Clinical Oncology	2022	32

Page 1